# NRX Pharmaceuticals, Inc.: Form DEF 14A, filed Feb 23, 2026

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: DEF 14A
- Filed: 2026-02-23
- Accepted by EDGAR: Feb 23, 2026, 17:00 ET
- Period: 2026-03-23
- Accession: 0001437749-26-005119
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926005119/nrxp20260218_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774926005119/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774926005119/nrxp20260218_def14a.htm

Filed Feb 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-005119. Last ingested by Listed: Nov 5, 2026, 19:01 ET. No prices; not investment advice.